Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Molecules (Basel, Switzerland)|July 27, 2022
In Silico Target Identification of Galangin, as an Herbal Flavonoid against CholangiocarcinomaBrinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, et al.
Scientific Reports|December 29, 2024
Development of chimeric MrNV virus-like particles capable of binding to SARS-CoV-2-susceptible cells and reducing infection by pseudovirus variantsSupawich Boonkua, Orawan Thongsum, Purimpuch Soongnart, et al.
Zoological Science|July 31, 2020
ECM-Body: A Cell-Free 3D Biomimetic Scaffold Derived from Intact Planarian BodyEkasit Sonpho, Chanida Wootthichairangsan, Miyuki Ishida, et al.
Antiviral Research|June 30, 2022
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse seraChotiwat Seephetdee, Kanit Bhukhai, Nattawut Buasri, et al.
Plos Pathogens|February 24, 2025
A ribosome-interacting jumbophage protein associates with the phage nucleus to facilitate efficient propagationWichanan Wannasrichan, Sucheewin Krobthong, Chase J Morgan, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
A phage nucleus-associated protein from the jumbophage Churi inhibits bacterial growth through protein translation interferenceWichanan Wannasrichan, Sucheewin Krobthong, Chase J Morgan, et al.
Scientific Reports|December 19, 2023
Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cellsKittiya Islam, Brinda Balasubramanian, Simran Venkatraman, et al.
Vaccines|June 2, 2021
Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2Chotiwat Seephetdee, Nattawut Buasri, Kanit Bhukhai, et al.
Pageof 5